Status | Study |
Recruiting |
Study Name: Inhibition of Anaphylaxis by Ibrutinib Condition: Food Allergy Anaphylaxis Food Date: 2017-05-05 Interventions: Drug: Ibrutinib Ibrutinib 420mg, PO once daily for 2-7 days |
Recruiting |
Study Name: Smartphone Apps for Pediatric Resuscitation Condition: Status Epilepticus Anaphylaxis Date: 2016-11-04 Interventions: Device: Smartphone apps If alr |
Recruiting |
Study Name: DEpth of EPinephrine Delivery With Auto-injectors Devices Condition: Anaphylactic Shock Date: 2016-08-29 Interventions: Other: skin ultrasound |
Active, not recruiting |
Study Name: Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device Condition: Anaphylaxis Date: 2016-07-22 Interventions: Behavioral: Device: Anapphylaxis |
Completed |
Study Name: One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish Condition: Food Allergy Date: 2015-12-09 Interventions: Other: Food allergy questionnaire |
Recruiting |
Study Name: PEAnut Anaphylaxis Predictors Condition: Peanut Hypersensitivity Anaphylaxis Date: 2015-04-19 Interventions: Other: Questionnaire 5 minute |
Recruiting |
Study Name: Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure Condition: Neuromuscular Blocking Agents Anaphylaxis Date: 2014-05-12 Interventions: Other: intradermal pholcodine allergy test in cases |
Completed |
Study Name: A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101) Condition: Hypersensitivity Anaphylaxis Date: 2014-01-03 Interventions: Drug: Sugammadex Sugammadex 4 |
Recruiting |
Study Name: Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy Condition: Food Allergy Anaphylaxis Date: 2013-01-21 |
Active, not recruiting |
Study Name: The Metabolomics of Anaphylaxis to Immunotherapy Condition: Anaphylaxis as a Result of Allergen or Venom Immunotherapy Date: 2012-08-07 |